(Total Views: 214)
Posted On: 11/01/2022 4:10:52 PM
Post# of 101
$RIGL News Article - Rigel Announces Top-line Results from FOCUS Phase 3 Clinical Trial of Fostamatinib in High Risk Hospitalized COVID-19 Patients https://marketwirenews.com/news-releases/rige...26510.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
